Maternal and Fetal Vascular Lesions of Malperfusion in the Placentas Associated with Fetal and Neonatal Death: Results of a Prospective Observational Study.

[1]  R. Redline,et al.  Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus , 2021, Modern Pathology.

[2]  W. Carlo,et al.  Stillbirth 2010–2018: a prospective, population-based, multi-country study from the Global Network , 2020, Reproductive Health.

[3]  H. van Goor,et al.  Altered Levels of Decidual Immune Cell Subsets in Fetal Growth Restriction, Stillbirth, and Placental Pathology , 2020, Frontiers in Immunology.

[4]  R. Silver,et al.  The association of stillbirth with placental abnormalities in growth-restricted and normally grown fetuses. , 2019, Paediatric and perinatal epidemiology.

[5]  C. Parker,et al.  Findings in Stillbirths Associated with Placental Disease , 2019, American Journal of Perinatology.

[6]  R. Romero,et al.  Mechanisms of death in structurally normal stillbirths , 2018, Journal of perinatal medicine.

[7]  A. Jeyabalan,et al.  Placental findings in non-hypertensive term pregnancies and association with future adverse pregnancy outcomes: a cohort study. , 2018, Placenta.

[8]  R. Redline,et al.  Fetal vascular malperfusion, an update , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[9]  L. Ernst.  Maternal vascular malperfusion of the placental bed , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  G. Ravikumar,et al.  Placenta in intrauterine fetal demise (IUFD): a comprehensive study from a tertiary care hospital , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[11]  Lindsay M. Parlberg,et al.  The project to understand and research preterm pregnancy outcomes and stillbirths in South Asia (PURPOSe): a protocol of a prospective, cohort study of causes of mortality among preterm births and stillbirths , 2018, Reproductive Health.

[12]  J. Stanek.  Placental examination in nonmacerated stillbirth versus neonatal mortality , 2018, Journal of perinatal medicine.

[13]  B. Hoffman,et al.  Maternal Vascular Malperfusion and Adverse Perinatal Outcomes in Low-Risk Nulliparous Women. , 2017, Obstetrics and gynecology.

[14]  R. Romero,et al.  Fetal death: an extreme manifestation of maternal anti-fetal rejection , 2017, Journal of perinatal medicine.

[15]  W. Parks.  Manifestations of Hypoxia in the Second and Third Trimester Placenta , 2017, Birth defects research.

[16]  C. Parker,et al.  Altered fetal growth, placental abnormalities, and stillbirth , 2017, PloS one.

[17]  B. Stoll,et al.  Associations between Maternal and Fetal Inherited Thrombophilias, Placental Characteristics Associated with Vascular Malperfusion, and Fetal Growth , 2017, TH Open.

[18]  P. D. Nicola,et al.  International estimated fetal weight standards of the INTERGROWTH‐21st Project , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[19]  R. Romero,et al.  Pravastatin for the prevention of adverse pregnancy outcome: preeclampsia and more? , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[20]  S. Caritis,et al.  Placental maternal vascular malperfusion and adverse pregnancy outcomes in gestational diabetes mellitus. , 2017, Placenta.

[21]  C. Parker,et al.  Diagnostic Tests for Evaluation of Stillbirth: Stillbirth Collaborative Research Network. , 2017, Obstetrics and gynecology.

[22]  M. Ashworth,et al.  Stillbirth and intrauterine fetal death: role of routine histopathological placental findings to determine cause of death , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[23]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[24]  R. Romero,et al.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. , 2016, American journal of obstetrics and gynecology.

[25]  R. Romero,et al.  The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia* , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[26]  R. Redline.  Classification of placental lesions. , 2015, American journal of obstetrics and gynecology.

[27]  N. Sebire,et al.  Systematic review of placental pathology reported in association with stillbirth. , 2014, Placenta.

[28]  C. Parker,et al.  Placental Findings in Singleton Stillbirths , 2014, Obstetrics and gynecology.

[29]  J. van der Meer,et al.  Evaluation of 1025 fetal deaths: proposed diagnostic workup. , 2012, American journal of obstetrics and gynecology.

[30]  C. Vogt,et al.  How Important is Placental Examination in Cases of Perinatal Deaths? , 2011, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[31]  R. Romero,et al.  The "Great Obstetrical Syndromes" are associated with disorders of deep placentation. , 2011, American journal of obstetrics and gynecology.

[32]  H. Pinar,et al.  Placenta and umbilical cord abnormalities seen with stillbirth. , 2010, Clinical obstetrics and gynecology.

[33]  A. Heazell,et al.  Can post-mortem examination of the placenta help determine the cause of stillbirth? , 2009, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[34]  R. Redline.  Placental pathology: a systematic approach with clinical correlations. , 2008, Placenta.

[35]  J. Kingdom,et al.  Placental diagnostic criteria and clinical correlation--a workshop report. , 2005, Placenta.

[36]  B. Richardson,et al.  The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. , 2001, American journal of obstetrics and gynecology.

[37]  S. Buyske,et al.  Clinical and pathologic correlates of stillbirths in a single institution , 1998, Acta obstetricia et gynecologica Scandinavica.

[38]  C. Langston,et al.  Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. , 1997, Archives of pathology & laboratory medicine.

[39]  F. Arias,et al.  Placental Histology and Clinical Characteristics of Patients With Preterm Premature Rupture of Membranes , 1997, Obstetrics and gynecology.

[40]  R. Naeye.  Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. , 1989, Human pathology.

[41]  I. Brosens,et al.  FETAL GROWTH RETARDATION AND THE MATERNAL ARTERIAL SUPPLY OF THE HUMAN PLACENTA IN THE ABSENCE OF SUSTAINED HYPERTENSION , 1980 .